| 000 | 01646 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250513065741.0 | ||
| 264 | 0 | _c19931126 | |
| 008 | 199311s 0 0 eng d | ||
| 022 | _a0002-9378 | ||
| 024 | 7 |
_a10.1016/0002-9378(93)90048-n _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPryde, P G | |
| 245 | 0 | 0 |
_aEffects of hydralazine on pregnant rats and their fetuses. _h[electronic resource] |
| 260 |
_bAmerican journal of obstetrics and gynecology _cOct 1993 |
||
| 300 |
_a1027-31 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAbnormalities, Drug-Induced |
| 650 | 0 | 4 | _aAdministration, Oral |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBirth Weight _xdrug effects |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFetus _xdrug effects |
| 650 | 0 | 4 |
_aHydralazine _xadministration & dosage |
| 650 | 0 | 4 |
_aHydronephrosis _xchemically induced |
| 650 | 0 | 4 | _aInjections, Subcutaneous |
| 650 | 0 | 4 |
_aLitter Size _xdrug effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMaternal Mortality |
| 650 | 0 | 4 |
_aOrgan Size _xdrug effects |
| 650 | 0 | 4 |
_aPlacenta _xanatomy & histology |
| 650 | 0 | 4 | _aPregnancy |
| 650 | 0 | 4 |
_aPregnancy, Animal _xdrug effects |
| 650 | 0 | 4 | _aRandom Allocation |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Sprague-Dawley |
| 650 | 0 | 4 |
_aWeight Gain _xdrug effects |
| 700 | 1 | _aAbel, E L | |
| 700 | 1 | _aHannigan, J | |
| 700 | 1 | _aEvans, M I | |
| 700 | 1 | _aCotton, D B | |
| 773 | 0 |
_tAmerican journal of obstetrics and gynecology _gvol. 169 _gno. 4 _gp. 1027-31 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/0002-9378(93)90048-n _zAvailable from publisher's website |
| 999 |
_c8237398 _d8237398 |
||